Jade Biosciences (JBIO) Prepaid Assets (2020 - 2026)

Jade Biosciences posted quarterly Prepaid Assets of $7.2 million for Q1 2026, up 2171.07% year-on-year from $318000.0 in Q1 2025, and down 42.95% on a QoQ basis from $12.7 million in Q4 2025.

Jade Biosciences (JBIO) has 7 years of Prepaid Assets data on file, last reported at $7.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Prepaid Assets rose 2171.07% year-over-year to $7.2 million; the trailing twelve-month figure through Mar 2026 stood at $7.2 million (up 2171.07% YoY), and the FY2025 full-year result was $12.7 million, up 4623.13% from the prior year.
  • Prepaid Assets for Q1 2026 stood at $7.2 million, down from $12.7 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $12.7 million in Q4 2025 and bottomed at $268000.0 in Q4 2024.
  • The 5-year median for Prepaid Assets is $2.0 million (2025), against an average of $3.0 million.
  • Peak annual rise in Prepaid Assets reached 4623.13% in 2025, while the deepest fall reached 83.6% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $478000.0 in 2022, then decreased by 21.55% to $375000.0 in 2023, then retreated by 28.53% to $268000.0 in 2024, then soared by 4623.13% to $12.7 million in 2025, then sank by 42.95% to $7.2 million in 2026.
  • The last three Prepaid Assets figures came in at $7.2 million (Q1 2026), $12.7 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Jade Biosciences 1.06 Bn 1.06 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 7.22 Mn
Dec 31, 2025 12.66 Mn
Sep 30, 2025 2.46 Mn
Jun 30, 2025 2.04 Mn
Mar 31, 2025 318,000.00
Dec 31, 2024 268,000.00
Sep 30, 2024 1.88 Mn
Jun 30, 2024 6.56 Mn
Mar 31, 2024 1.94 Mn
Dec 31, 2023 375,000.00
Sep 30, 2023 2.40 Mn
Jun 30, 2023 2.37 Mn
Mar 31, 2023 1.11 Mn
Dec 31, 2022 478,000.00
Sep 30, 2022 2.58 Mn
Jun 30, 2022 1.46 Mn
Mar 31, 2022 4.81 Mn
Dec 31, 2021 240,000.00
Sep 30, 2021 2.22 Mn
Jun 30, 2021 159,000.00
Dec 31, 2020 23,000.00